Latest news and press releases about Abrdn Healthcare Investors (HQH): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.
Price
| Price | $21.32 |
| Market Cap | $1.2B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 11.55 |
| Price / Book | 1.04 |
| EV / EBITDA | 13.04 |
| Dividend Yield | 11.62% |
Profitability
| Return on Equity | 9.16% |
| Return on Invested Capital | 9.00% |
| Return on Assets | 8.99% |
| Gross Margin | 100.00% |
| Operating Margin | 98.80% |
| Net Margin | 98.80% |
Related companies: BCSF · CGBD · HRZN · KBDC · MFIC · NMFC · PFLT
Explore sector: Financial Services · Asset Management
More sections of HQH: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks